NCT05254431

Brief Summary

The term "Overlap Syndrome" (OS) is used to describe the presence of both chronic obstructive pulmonary disease (COPD) and obstructive sleep apnea (OSA) in a single patient. Due to premature aging, patients with OS are prone to developing functional decline up to 20 years earlier than the general population. The International Classification of Functioning, Disability and Health (ICF) evaluates functional status in chronic pulmonary disease globally in 5 domains. The investigators propose to study validated outcomes in 3 of these domains: 1) participation in life situations; 2) physical activity; and 3) cardiovascular health. The investigators long-term goal is to develop an exercise strategy tailored to Veterans with OS which will reduce the risk of functional decline through increased PA.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
28

participants targeted

Target at below P25 for not_applicable

Timeline
11mo left

Started Apr 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress82%
Apr 2022Apr 2027

First Submitted

Initial submission to the registry

January 28, 2022

Completed
27 days until next milestone

First Posted

Study publicly available on registry

February 24, 2022

Completed
1 month until next milestone

Study Start

First participant enrolled

April 1, 2022

Completed
5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2027

Last Updated

April 24, 2026

Status Verified

April 1, 2026

Enrollment Period

5 years

First QC Date

January 28, 2022

Last Update Submit

April 21, 2026

Conditions

Keywords

COPDOSAOverlap Syndrome

Outcome Measures

Primary Outcomes (3)

  • Scale number on Epworth Sleepiness Scale

    Change from baseline ESS at 12 weeks ESS is daytime sleepiness scale, lower numbers better Scale goes from 0- not sleepy at all; to 20 -very sleepy

    12 weeks

  • Number of Daily Steps

    Change from baseline in Daily Steps at 12 weeks All participants will wear a wrist accelerometer (ActiGraph wGT3X-BT) for 7 days at baseline and the end of intervention phase to record daily steps. ActiLife software will be used to run validation algorithms and calculate mean daily steps.

    12 weeks

  • Concentration of Serum hs-CRP (mg/dL)

    Change from baseline in Serum hs-CRP (mg/dL) at 12 weeks

    12 weeks

Study Arms (2)

Exercise

EXPERIMENTAL

The Experimental Design is a randomized trial of Moderate intensity interval training (5-minute intervals at 50% VO2peak 3 times weekly for 12 weeks) in Veterans with COPD and OSA compared with standard of care controls

Behavioral: Exercise

Usual Care

NO INTERVENTION

Participants in the control group will be instructed to maintain their routine activity level for 12 weeks

Interventions

ExerciseBEHAVIORAL

Novel Moderate Intensity Interval Exercise The Experimental Design is a randomized trial of moderate intensity interval training (5-minute intervals at 50% VO2peak 3 times weekly for 12 weeks) in Veterans with COPD and OSA compared with standard of care controls

Also known as: MIIT
Exercise

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of COPD and OSA, i.e., Overlap Syndrome Diagnosis of Overlap Syndrome (both COPD and OSA), confirmed in CPRS from spirometry or pulmonary function test of FEV1/FVC \<70 for COPD and a polysomnogram or home-based study for OSA.
  • Montreal Cognitive Assessment (MoCA) \>20

You may not qualify if:

  • CAD, as defined by anyone of the following: history of CABG, prior positive stress test for ischemia, infarction or angina or medical problem
  • Orthopedic problems as defined by joint pain limiting ambulation
  • Fall risk, defined as more than 2 falls in the prior month
  • Hospitalization in prior month
  • Daytime home oxygen 6. Participation in structured exercise, defined by the Physical Activity Scale for the Elderly (PASE) as more than 1 hour of activity spent in moderate activity and any strenuous activity performed over prior 7 days.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Salem VA Medical Center, Salem, VA

Salem, Virginia, 24153-6404, United States

RECRUITING

MeSH Terms

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

Exercise

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Madalina Macrea, MD PhD

    Salem VA Medical Center, Salem, VA

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Madalina Macrea, MD PhD

CONTACT

Kimberly L Birkett, MPH BS

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: Exercise trial of 12 weeks moderate intensity interval exercise in Veterans with COPD and OSA that compares exercise group to standard of care control group
Sponsor Type
FED
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 28, 2022

First Posted

February 24, 2022

Study Start

April 1, 2022

Primary Completion (Estimated)

April 1, 2027

Study Completion (Estimated)

April 1, 2027

Last Updated

April 24, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations